Inflammation & Allergy - Drug Targets (Discontinued)
Title: Editorial from Editorial Board Member [ Thoughts on Impact Factors and Editing of Medical Journals ]
Volume: 9 Issue: 1
Author(s): Armen Yuri Gasparyan
Affiliation:
Export Options
About this article
Cite this article as:
Gasparyan Yuri Armen, Editorial from Editorial Board Member [ Thoughts on Impact Factors and Editing of Medical Journals ], Inflammation & Allergy - Drug Targets (Discontinued) 2010; 9 (1) . https://dx.doi.org/10.2174/187152810791292908
DOI https://dx.doi.org/10.2174/187152810791292908 |
Print ISSN 1871-5281 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4055 |
9
Related Articles
-
Inflammatory Disorders and Atherosclerosis: New Therapeutic Approaches
Current Pharmaceutical Design Current Anti-Inflammatory Therapies and the Potential of Secretory Phospholipase A2 Inhibitors in the Design of New Anti-Inflammatory Drugs: A Review of 2012 - 2018
Current Medicinal Chemistry HIV-1 Neutralization: Mechanisms and Relevance to Vaccine Design
Current HIV Research Pharmacology and Toxicology of Cannabis Derivatives and Endocannabinoid Agonists
Recent Patents on CNS Drug Discovery (Discontinued) Modifier Gene Studies to Identify New Therapeutic Targets in Cystic Fibrosis
Current Pharmaceutical Design Viruses and Multiple Sclerosis
CNS & Neurological Disorders - Drug Targets Medicinal Compound Celastrol As a Potential Clinical Anticancer Drug: Lessons Learned From Preclinical Studies
Clinical Cancer Drugs Intracoronary Brachytherapy - Clinical State and Pathophysiological Considerations
Current Pharmaceutical Design <i>In Silico</i> Study Examining New Phenylpropanoids Targets with Antidepressant Activity
Current Drug Targets Rexinoids for Prevention and Treatment of Cancer: Opportunities and Challenges
Current Topics in Medicinal Chemistry Protective Effect of Natural Antioxidants on Heart Against Ischemia-Reperfusion Damage
Current Pharmaceutical Biotechnology Lipid Alterations in the Earliest Clinically Recognizable Stage of Alzheimers Disease: Implication of the Role of Lipids in the Pathogenesis of Alzheimers Disease
Current Alzheimer Research Ablation of T-Helper 1 Cell Derived Cytokines and of Monocyte-Derived Tumor Necrosis Factor-α in Hereditary Hemorrhagic Telangiectasia: Immunological Consequences and Clinical Considerations
Current Pharmaceutical Design An Efficient Gram Scale Synthesis of Aryl Iodides from Aryl Diazofluoroborates in Water under Mild Conditions
Letters in Organic Chemistry Can Targeting the Incretin Pathway Dampen RAGE-Mediated Events in Diabetic Nephropathy?
Current Drug Targets 1, 2, 4-Oxadiazole Incorporated Ketoprofen Analogues in Search of Safer Non-steroidal Anti-inflammatory Agents: Design, Syntheses, Biological Evaluation and Molecular Docking Studies
Letters in Drug Design & Discovery Mammalian Target of Rapamycin as a Therapeutic Target in Leukemia
Current Molecular Medicine Therapeutic Neovascularization by the Implantation of Autologous Mononuclear Cells in Patients with Connective Tissue Diseases
Current Pharmaceutical Design Dynamical Behaviors of the Transcriptional Network Including REST and miR-21 in Embryonic Stem Cells
Current Bioinformatics Involvement of Cannabinoids in Cellular Proliferation
Mini-Reviews in Medicinal Chemistry